About Us
BACKGROUND
Over the past several years, many pioneering gene and cell therapies have been brought to market and delivered durable results for unprecedented price points. In the future, many more personalized therapies will be marketed for more persons suffering from previously incurable diseases. That will cause much greater strain for payers, patients, and others to afford and access, let alone conduct due diligence and determine the durability of therapies ready for patient delivery.
T5 Advisors (T5) is focused on the opportunity to accumulate the handful of patients requiring personalized therapies from the ~170,000,000 members of commercial health plans (and indeed many more for the growing Government plans). T5 is best positioned then to support clinical, operational and financial management for the entire patient journey by coordination or new service development required to engage the patient longitudinally and obtain the clinical contact and data required for gene and cell therapies to deliver measurable enhanced patient outcomes.
VISION
To provide patients with easier access to personalized therapies that meet an appropriate clinical need.
MISSION
Use technology-enabled collaboration, data, and analytics to enhance patient outcomes.